BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25148110)

  • 21. The influence of hippocampal dopamine D2 receptor losses on episodic-memory decline across 5 years is moderated by BDNF and KIBRA polymorphisms.
    Papenberg G; Karalija N; Johansson J; Andersson M; Axelsson J; Riklund K; Lindenberger U; Nyberg L; Bäckman L
    Cortex; 2024 Jul; 176():53-61. PubMed ID: 38749085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status.
    Vossen H; Kenis G; Rutten B; van Os J; Hermens H; Lousberg R
    PLoS One; 2010 Oct; 5(10):e13641. PubMed ID: 21049025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications.
    Tan HY; Chen AG; Chen Q; Browne LB; Verchinski B; Kolachana B; Zhang F; Apud J; Callicott JH; Mattay VS; Weinberger DR
    Mol Psychiatry; 2012 Oct; 17(10):1007-16. PubMed ID: 21788944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The BDNF Val66Met Polymorphism, Regular Exercise, and Cognition: A Systematic Review.
    Liu T; Li H; Colton JP; Ge S; Li C
    West J Nurs Res; 2020 Aug; 42(8):660-673. PubMed ID: 32075548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT.
    Payne NA; Prudic J
    J Psychiatr Pract; 2009 Sep; 15(5):346-68. PubMed ID: 19820553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Pilot Study of Adjunctive Group Therapy to Enhance Coping With Cognitive Challenges and Support Cognitive Health After Electroconvulsive Therapy.
    Copersino ML; DeTore NR; Piltch C; Bolton P; Henderson T; Davis VF; Eberlin ES; Kadden L; McGurk SR; Seiner SJ; Mueser KT
    J ECT; 2023 Dec; 39(4):248-254. PubMed ID: 37530733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients.
    Ng DQ; Cheng I; Wang C; Tan CJ; Toh YL; Koh YQ; Ke Y; Foo KM; Chan RJ; Ho HK; Chew L; Bin Harunal Rashid MF; Chan A
    Sci Rep; 2023 Sep; 13(1):16298. PubMed ID: 37770565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning.
    Frank MJ; Moustafa AA; Haughey HM; Curran T; Hutchison KE
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16311-6. PubMed ID: 17913879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warning: Medical records about ECT-induced memory impairment matter.
    Read J
    J Affect Disord; 2024 Sep; 360():137-138. PubMed ID: 38821363
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluating depressive symptoms, BDNF Val66Met, and APOE-ε4 as moderators of response to computerized cognitive training in heart failure.
    Pressler SJ; Jung M; Giordani B; Titler MG; Gradus-Pizlo I; Lake KR; Wierenga KL; Clark DG; Perkins SM; Smith DG; Mocci E; Dorsey SG
    Heart Lung; 2023; 59():146-156. PubMed ID: 36805256
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Altshuler DB; Wang L; Zhao L; Miklja Z; Linzey J; Brezzell A; Kakaizada S; Krishna S; Orringer DA; Briceño EM; Gabel N; Hervey-Jumper SL
    Neurooncol Pract; 2019 Sep; 6(5):375-385. PubMed ID: 31555452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive effects of electroconvulsive therapy in depressed adolescents.
    Ghaziuddin N; McClintock SM; Maixner DF; Miller LR; Husain M; Wachtel LE; Siddiqi SH; Flood M; Weinstein S; Frye MA; Weiner RD;
    J Affect Disord; 2024 Jul; 356():32-33. PubMed ID: 38479508
    [No Abstract]   [Full Text] [Related]  

  • 33. The Rosetta Phenotype Harmonization Method Facilitates Finding a Relationship Quantitative Trait Locus for a Complex Cognitive Trait.
    Petrill SA; Klamer BG; Buyske S; Willcutt EG; Gruen JR; Francis DJ; Flax JF; Brzustowicz LM; Bartlett CW
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erroneous conclusions about the long-term cognitive effects of electroconvulsive therapy.
    Pandey A; Joseph R; Arumugham SS; Thirthalli J
    Psychiatry Res; 2024 May; 335():115864. PubMed ID: 38547602
    [No Abstract]   [Full Text] [Related]  

  • 35. Potential moderators of physical activity on brain health.
    Leckie RL; Weinstein AM; Hodzic JC; Erickson KI
    J Aging Res; 2012; 2012():948981. PubMed ID: 23304508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time.
    Bus BA; Molendijk ML; Tendolkar I; Penninx BW; Prickaerts J; Elzinga BM; Voshaar RC
    Mol Psychiatry; 2015 May; 20(5):602-8. PubMed ID: 25155878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of brief and ultrabrief pulse right unilateral electroconvulsive therapy.
    Loo CK; Katalinic N; Smith DJ; Ingram A; Dowling N; Martin D; Addison K; Hadzi-Pavlovic D; Simpson B; Schweitzer I
    Int J Neuropsychopharmacol; 2014 Dec; 18(1):. PubMed ID: 25522389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and biological predictors of response to electroconvulsive therapy (ECT): a review.
    Pinna M; Manchia M; Oppo R; Scano F; Pillai G; Loche AP; Salis P; Minnai GP
    Neurosci Lett; 2018 Mar; 669():32-42. PubMed ID: 27793702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic mechanisms of electroconvulsive therapy response in depression.
    Benson-Martin JJ; Stein DJ; Baldwin DS; Domschke K
    Hum Psychopharmacol; 2016 May; 31(3):247-51. PubMed ID: 27062668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between COMT gene Val108/158Met and antidepressive treatment response: A meta-analysis.
    Tang Z; Zhang S; Guo D; Wang H
    Gene; 2020 Apr; 734():144333. PubMed ID: 31972309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.